Preview: Revolution Medicines's Earnings
Portfolio Pulse from Benzinga Insights
Revolution Medicines (NASDAQ:RVMD) is set to release its latest quarterly earnings report on November 6, 2023. Analysts estimate an earnings per share (EPS) of $-1.01. The company's past performance shows a pattern of share price changes following earnings reports. The stock was trading at $21.15 as of November 2, with a 52-week increase of 19.37%.
November 03, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Revolution Medicines is expected to report an EPS of $-1.01 in its upcoming earnings. The company's stock price has historically been affected by its earnings reports.
The upcoming earnings report is a significant event for Revolution Medicines. The company's past earnings have shown a pattern of influencing its stock price, either positively or negatively. However, it's uncertain how the upcoming earnings will affect the stock price, hence the neutral score.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100